Sandu Pharmaceuticals Limited (BOM:524703)
India
· Delayed Price · Currency is INR 51.54
-0.88 (-1.68%)
At close: Jun 9, 2025
Sandu Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 15.52 | 14.61 | 15.21 | 15.89 | 10.93 | Upgrade
|
| Depreciation & Amortization | 6.71 | 5.67 | 5 | 4.97 | 5.23 | Upgrade
|
| Other Amortization | - | 0.16 | 0.17 | 0.34 | 0.34 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.61 | 0.43 | 0.38 | 0.4 | 1.25 | Upgrade
|
| Other Operating Activities | -1.1 | -1.03 | -0.8 | -0.85 | 0.71 | Upgrade
|
| Change in Accounts Receivable | -0.5 | -1.19 | -8.38 | 13.17 | -7.92 | Upgrade
|
| Change in Inventory | -18.98 | 20.75 | -30.53 | -1.34 | 32.24 | Upgrade
|
| Change in Accounts Payable | 2.92 | -42.06 | 15.8 | 1.48 | 9.12 | Upgrade
|
| Change in Other Net Operating Assets | 3.31 | 10.25 | 5.38 | -24.55 | 24.01 | Upgrade
|
| Operating Cash Flow | 9.48 | 7.6 | 2.21 | 9.49 | 75.9 | Upgrade
|
| Operating Cash Flow Growth | 24.81% | 243.69% | -76.69% | -87.50% | 22.38% | Upgrade
|
| Capital Expenditures | -9.38 | -14.25 | -10.69 | -8.41 | -1.27 | Upgrade
|
| Investment in Securities | 6.41 | -0.41 | 14.47 | -47.13 | -56.43 | Upgrade
|
| Other Investing Activities | 1.1 | 1.59 | 1.58 | 0.82 | 1.93 | Upgrade
|
| Investing Cash Flow | -1.86 | -13.07 | 5.37 | -54.72 | -55.76 | Upgrade
|
| Long-Term Debt Issued | 4.14 | 0.63 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.19 | -12.26 | Upgrade
|
| Total Debt Repaid | - | - | - | -0.19 | -12.26 | Upgrade
|
| Net Debt Issued (Repaid) | 4.14 | 0.63 | - | -0.19 | -12.26 | Upgrade
|
| Issuance of Common Stock | - | - | 13.2 | 13.81 | 26.38 | Upgrade
|
| Common Dividends Paid | -7.73 | -7.25 | -6.61 | -3.17 | - | Upgrade
|
| Other Financing Activities | -1.04 | -0.63 | -0.8 | -1.1 | -1.15 | Upgrade
|
| Financing Cash Flow | -4.62 | -7.25 | 5.79 | 9.34 | 12.97 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | -0 | Upgrade
|
| Net Cash Flow | 3 | -12.71 | 13.37 | -35.89 | 33.11 | Upgrade
|
| Free Cash Flow | 0.1 | -6.65 | -8.48 | 1.08 | 74.63 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -98.56% | 22.55% | Upgrade
|
| Free Cash Flow Margin | 0.01% | -0.99% | -1.30% | 0.16% | 12.70% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.69 | -0.90 | 0.13 | 10.54 | Upgrade
|
| Cash Interest Paid | 1.04 | 0.16 | 0.24 | 0.74 | 0.65 | Upgrade
|
| Cash Income Tax Paid | 5.83 | 4.99 | 7 | 8.77 | 4.58 | Upgrade
|
| Levered Free Cash Flow | -1.82 | -8.99 | -11.3 | -1.07 | 57.97 | Upgrade
|
| Unlevered Free Cash Flow | -1.17 | -8.65 | -10.85 | -0.61 | 58.37 | Upgrade
|
| Change in Net Working Capital | 11.59 | 10.93 | 17.64 | 12.15 | -44.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.